239 related articles for article (PubMed ID: 12865039)
1. The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics.
BENEDICT Group
Control Clin Trials; 2003 Aug; 24(4):442-61. PubMed ID: 12865039
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial.
Ruggenenti P; Remuzzi G
J Hypertens Suppl; 1998 Jan; 16(1):S95-7. PubMed ID: 9534106
[TBL] [Abstract][Full Text] [Related]
3. Preventing microalbuminuria in type 2 diabetes.
Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
5. Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial.
Ruggenenti P; Fassi A; Ilieva A; Iliev IP; Chiurchiu C; Rubis N; Gherardi G; Ene-Iordache B; Gaspari F; Perna A; Cravedi P; Bossi A; Trevisan R; Motterlini N; Remuzzi G;
J Hypertens; 2011 Feb; 29(2):207-16. PubMed ID: 21243736
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
Remuzzi G; Macia M; Ruggenenti P
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
[TBL] [Abstract][Full Text] [Related]
7. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.
Boero R; Rollino C; Massara C; Vagelli G; Gonella M; Berto IM; Bajardi P; Perosa P; Malcangi U; Giorgi MP; Ghezzi PM; Borzumati M; Baroni AM; Cogno C; Triolo G; Angelini D; Antonelli A; Quarello F
J Nephrol; 2001; 14(1):15-8. PubMed ID: 11281338
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of microalbuminuria in type 2 diabetes. BENEDICT study].
Nitschmann S
Internist (Berl); 2006 Feb; 47(2):199-200; discussion 200. PubMed ID: 16416298
[No Abstract] [Full Text] [Related]
9. Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.
Sharma SK; Ruggenenti P; Remuzzi G
Vasc Health Risk Manag; 2007; 3(4):453-65. PubMed ID: 17969376
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.
Toto RD; Tian M; Fakouhi K; Champion A; Bacher P
J Clin Hypertens (Greenwich); 2008 Oct; 10(10):761-9. PubMed ID: 19090877
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic management of diabetic nephropathy.
Vivian EM; Rubinstein GB
Clin Ther; 2002 Nov; 24(11):1741-56; discussion 1719. PubMed ID: 12501871
[TBL] [Abstract][Full Text] [Related]
12. [Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study].
Goicolea I; Fernández González R; Piniés J; Garrido J; Martínez JM; Armenteros S; Moreno Carretero E
Nefrologia; 2002; 22(2):170-8. PubMed ID: 12085418
[TBL] [Abstract][Full Text] [Related]
13. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
14. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
De Cosmo S; Motterlini N; Prudente S; Pellegrini F; Trevisan R; Bossi A; Remuzzi G; Trischitta V; Ruggenenti P;
Diabetes; 2009 Dec; 58(12):2920-9. PubMed ID: 19720797
[TBL] [Abstract][Full Text] [Related]
15. Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease.
Hemmelder MH; de Zeeuw D; de Jong PE
Nephrol Dial Transplant; 1999 Jan; 14(1):98-104. PubMed ID: 10052485
[TBL] [Abstract][Full Text] [Related]
16. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Bakris GL; Weir MR; DeQuattro V; McMahon FG
Kidney Int; 1998 Oct; 54(4):1283-9. PubMed ID: 9767545
[TBL] [Abstract][Full Text] [Related]
17. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
[TBL] [Abstract][Full Text] [Related]
18. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
Messerli F; Frishman WH; Elliott WJ
Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
[TBL] [Abstract][Full Text] [Related]
19. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.
DeQuattro V; Lee D; Messerli F
Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
